Quote | AdvisorShares Psychedelics ETF (NYSE:PSIL)
Last: | $1.11 |
---|---|
Change Percent: | 2.75% |
Open: | $1.06 |
Close: | $1.11 |
High: | $1.11 |
Low: | $1.06 |
Volume: | 40,435 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | AdvisorShares Psychedelics ETF (NYSE:PSIL)
2024-05-23 12:15:00 ET Summary Regulatory risk in the psychedelic industry is decreasing, which is a positive sign for investors. Institutional investors are becoming more willing to invest in leading psychedelic companies through private placements. Analyst Alex Carchidi disc...
2024-05-07 05:54:17 ET More on psychedelic therapies MindMed: Breakthrough Status From FDA For LSD Therapy COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way? Mind Medicine: GAD Program Success Continues With BTD MindMed releases promising data on LSD-...
Message Board Posts | AdvisorShares Psychedelics ETF (NYSE:PSIL)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
AdvisorShares Psychedelics ETF Company Name:
PSIL Stock Symbol:
NYSE Market:
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) PR Newswire Designed for sophisticated investors, MSOX seeks investment returns two-times the daily performance of the AdvisorShares Pure US Cannabis ETF (Ticker: MSOS) ...
Renewed interest in psychedelics in both public and scientific spaces has increased investor interest in psychedelic stocks. The psychedelic market is projected to achieve a valuation of $10.7 billion by 2027 , and investors are looking to cash in on the industry before it is satura...